Detection and prevalence of inducible clindamycin resistance in staphylococci

Journal of Medical Microbiology

Volumn 56, Issue 3, 2007, Pages 342-345

  Yilmaz, Gurdal ^a   Aydin, Kemalettin ^a   Iskender, Serap ^a   Caylan, Rahmet ^a   Koksal, Iftihar ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; METICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOGRAMIN B;

EID: 33847670929     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46761-0     Document Type: Article

References (23)

1. Azap, O. K., Arslan, H., Timurkaynak, F., Yapar, G., Oruc, E. & Gagir, U. (2005). Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey. Clin Microbiol Infect 11, 582-584.
2. Drinkovic, D., Fuller, E. R., Shore, K. P., Holland, D. J. & Ellis-Pegler, R. (2001). Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 48, 315-316.
3. Fiebelkorn, K. R., Crawford, S. A., McElmeel, M. L. & Jorgensen, J. H. (2003). Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 41, 4740-4744.
4. Fokas, S., Fokas, S., Tsironi, M., Kalkani, M. & Dionysopouloy, M. (2005). Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect 11, 337-340.
5. Frank, A. L, Marcinak, J. F., Mangat, P. D., Tjhio, J. T., Kelkar, S., Schreckenberger, P. C. & Quinn, J. P. (2002). Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 21, 530-534.
6. Goldman, R. C. & Capobianco, J. O. (1990). Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother 34, 1973-1980.
7. Groom, A. V., Wolsey, D. H., Naimi, T. S., Smith, K., Johnson, S., Boxrud, D., Moore, K. A. & Cheek, J. E. (2001). Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286, 1201-1205.
8. Hussain, F. M., Boyle-Vavra, S., Bethel, C. D. & Daum, R. S. (2000). Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 19, 1163-1166.
9. Kasten, M. J. (1999). Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc 74, 825-833.
10. Leclercq, R. & Courvalin, P. (1991a). Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 35, 1267-1272.
11. Leclercq, R. & Courvalin, P. (1991b). Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother 35, 1273-1276.
12. McGehee, R. F., Barret, F. F. & Finland, F. (1969). Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. Antimicrob Agents Chemother 13, 392-397.
13. Naimi, T. S., LeDell, K. H., Boxrud, D. J., Groom, A. V., Steward, C. D., Johnson, S. K., Besser, J. M., O'Boyle, C., Danila, R. N. & other authors (2001). Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus: Minnesota, 1996-98. Clin Infect Dis 33, 990-996.
14. National Committee for Clinical Laboratory Standards (2003). Performance Standards for Antimicrobial Disk Susceptibility Tests, approved standard M2-A8. Wayne, PA: National Committee for Clinical Laboratory Standards.
15. National Committee for Clinical Laboratory Standards (2004). Performance Standards for Antimicrobial Disk Susceptibility Testing, fourteenth informational supplement, document M100-S14. Wayne, PA: National Committee for Clinical Laboratory Standards.
16. Panagea, S., Perry, J. D. & Gould, F. K. (1999). Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 44, 581-582.
17. Rao, G. G. (2000). Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 45, 715.
18. Schreckenberger, P. C., Ilendo, E. & Ristow, K. L. (2004). Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 42, 2777-2779.
19. Siberry, G. K., Tekle, T., Carroll, K. & Dick, J. (2003). Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 37, 1257-1260.
20. Van der Heijden, I. M., Sinto, S., Oplustil, C. & Mendes, C. (2001). In Abstracts of the 101st General Meeting of the American Society for Microbiology 2001, abstract A-86. Washington, DC: American Society for Microbiology.
21. Van Horn, K. G. & Toth, C. (2003). In Abstracts of the 103rd General Meeting of the American Society for Microbiology 2003, abstract C-074. Washington, DC: American Society for Microbiology.
22. Weisblum, B. & Demohn, V. (1969). Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol 98, 447-452.
23. Werckenthin, C., Schwarz, S. & Westh, H. (1999). Structural alterations in the translational attenuator of constitutively expressed ermC genes. Antimicrob Agents Chemother 43, 1681-1685.